In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 3340-78-1, name is 2-Phenyl-1,2,3,4-tetrahydroisoquinoline, introducing its new discovery. SDS of cas: 3340-78-1
Copper complexes visible light catalytic 2-methyl quinoline with tetrahydroisoquinoline coupling reaction method for the preparation of (by machine translation)
The present invention relates to a 2,9-dimethyl -4,7-diphenyl -1,10-O-phenanthrene carborane double-phenyl a phosphine price copper complexes in the visible light catalytic 2-methyl quinoline compounds with tetrahydroisoquinoline compound dehydrogenation method of coupling reaction. The preparation method of this invention is: the photocatalyst 2,9-dimethyl -4,7-diphenyl -1,10-O-phenanthrene carborane double-phenyl a phosphine price copper complex, the corresponding 2-methyl quinoline, tetrahydroisoquinoline and inter-methyl benzoic acid according to 0.015: 2:1:3 molar ratio of mixing, adding solvent acetonitrile and methanol, acetonitrile and methanol in accordance with the 1:1 volume ratio of mixing, the reaction system is filled with oxygen, mercury distance of 2 cm is at 3.5w white light of the lamp strip led, in 35 hours later, the solvent out of the reaction system, through the silica gel column chromatography separation, to obtain the corresponding product. The beneficial effect of this method for the use of visible photocatalytic reaction, environmental protection and low carbon. (by machine translation)
We¡¯ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 3340-78-1, and how the biochemistry of the body works.SDS of cas: 3340-78-1
Reference£º
Tetrahydroisoquinoline – Wikipedia,
1,2,3,4-Tetrahydroisoquinoline | C9H11N – PubChem